Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)Francesco Patti, Diego Centonze, Raffaella Clerici et al.|Multiple Sclerosis and Related Disorders|2020Cited by 33
Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regionsCourtney Bishop, Adam Waldman, Rexford D. Newbould et al.|NeuroImage Clinical|2016Cited by 29
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy studySebastiano Bucello, Luca Prosperini, Pietro Annovazzi et al.|Journal of Neurology|2021Cited by 22